RxDoctor Payments Data

Haley Mertz, PA

Physician Assistant · Dalton, GANPI 1164931622

Payments from drug & device makers

$13,024in general payments, 2019–2025

Across 770 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$1K
  • Acadia Pharmaceuticals Inc$772
  • Amneal Pharmaceuticals LLC$605
  • Eisai Inc.$595
  • Neurocrine Biosciences, Inc.$428
  • plus $7K from 53 others

What the payments were for

  • Food & beverage$12,978100%
  • Education$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)139$1,771
UCB, Inc.83$1,474
Acadia Pharmaceuticals Inc55$772
Amneal Pharmaceuticals LLC38$605
Eisai Inc.30$595
Neurocrine Biosciences, Inc.24$428
Bristol Myers Squibb18$411
Pfizer28$404
Jazz Pharmaceuticals Inc.20$351
SK Life Science, Inc.14$346
MDD US Operations, LLC8$343
Teva Pharmaceuticals USA, Inc.20$342
EMD Serono, Inc.18$330
Biogen18$328
Upsher-smith Laboratories LLC18$307
Novartis20$298
Kyowa Kirin, Inc.15$287
Impel Pharmaceuticals Inc.16$235
Lilly USA, LLC12$233
AstraZeneca(2 entities)12$224
Lundbeck LLC13$224
Argenx US, Inc.9$215
Johnson & Johnson(2 entities)13$207
Catalyst Pharmaceuticals, Inc.10$187
Amgen10$178
Neurelis, Inc.8$163
Biohaven Pharmaceutical Holding Company Ltd.14$158
Mallinckrodt Hospital Products Inc.6$145
Vanda Pharmaceuticals Inc.6$123
Otsuka America Pharmaceutical, Inc.6$122
CSL Behring5$106
Cycle Pharmaceuticals Inc4$103
Supernus Pharmaceuticals, Inc.6$85
Axsome Therapeutics, Inc.4$83
Greenwich Biosciences, Inc.5$81
Biohaven Pharmaceuticals, Inc.6$76
Impel Pharmaceuticals LLC3$61
Genentech USA, Inc.3$60
Aucta Pharmaceuticals, Inc.3$59
Azurity Pharmaceuticals, Inc.3$58
Acorda Therapeutics, Inc3$54
Grifols USA, LLC2$42
Merz Pharmaceuticals, LLC2$39
Arbor Pharmaceuticals, Inc.3$39
Avion Pharmaceuticals2$30
GE HealthCare2$29
Microtransponder, Inc.1$25
TG Therapeutics, Inc.1$21
Sumitomo Pharma America, Inc.1$18
Sanofi1$17
Almatica Pharma LLC1$16
Aquestive Therapeutics, Inc.1$16
Avanir Pharmaceuticals, Inc.1$16
Scilex Pharmaceuticals Inc.1$15
Abbott1$15
C2n Diagnostics, LLC1$14
Biodelivery Sciences International, Inc.1$14
Zogenix Inc.1$13
Currax Pharmaceuticals LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,024 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$43,504
Medicare patients
216
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant207$251,538
BotoxOnabotulinumtoxina133$172,189
Emgality PenGalcanezumab-Gnlm239$171,294
QuliptaAtogepant145$162,207
Nurtec OdtRimegepant Sulfate106$127,223
Aimovig AutoinjectorErenumab-Aooe121$98,413
TrudhesaDihydroergotamine Mesylate17$96,045
Ajovy AutoinjectorFremanezumab-Vfrm108$87,641
ReyvowLasmiditan Succinate26$18,640
Sumatriptan Succinate164$17,781
Ajovy SyringeFremanezumab-Vfrm17$12,109
Sumatriptan30$5,449
Memantine Hcl115$2,629
Donepezil Hcl245$1,912
RizatriptanRizatriptan Benzoate97$1,507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Botox, Qulipta$1,771$585,934485 claims
PfizerNurtec Odt$404$127,223106 claims
Impel Pharmaceuticals Inc.Trudhesa$235$96,04517 claims
Lilly USA, LLCReyvow$233$18,64026 claims
Upsher-smith Laboratories LLCTopiramate$307$1,343138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →